Description
MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE
First action · last action
2019-10-22 · 2026-05-13
Transactions
18
First transaction's obligation
$267,287
Base + all options value (sum of deltas)
$2,423,976
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
2
SDVOSB flag on record
No
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 18 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-10-22+$267,287= $267,287
- Mod P000012020-10-08+$337,226= $604,513
- Mod P000022020-10-30+$50,321= $654,834
- Mod P000032020-11-09+$0= $654,834
- Mod P000042021-03-31-$195,807= $459,027
- Mod P000052021-10-22+$626,441= $1,085,467
- Mod P000062021-11-02+$0= $1,085,467
- Mod P000072021-12-13+$0= $1,085,467
- Mod P000082022-08-10-$101,227= $984,241
- Mod P000092022-10-13+$626,441= $1,610,681
- Mod P000102023-01-10+$0= $1,610,681
- Mod P000112023-10-19+$621,820= $2,232,501
- Mod P000122024-06-05-$360= $2,232,141
- Mod P000132024-06-14-$7,734= $2,224,407
- Mod P000142024-10-28+$11,287= $2,235,694
- Mod P000152025-01-31+$0= $2,235,694
- Mod P000162025-11-03-$10= $2,235,684
- Mod P000172026-05-13-$85,128= $2,150,556
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-10-22 | +$267,287 | $267,287 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00001· EXERCISE AN OPTION | 2020-10-08 | +$337,226 | $604,513 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-10-30 | +$50,321 | $654,834 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-11-09 | +$0 | $654,834 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-03-31 | −$195,807 | $459,027 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00005· EXERCISE AN OPTION | 2021-10-22 | +$626,441 | $1,085,467 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2021-11-02 | +$0 | $1,085,467 | EO14042 - MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00007· OTHER ADMINISTRATIVE ACTION | 2021-12-13 | +$0 | $1,085,467 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00008· OTHER ADMINISTRATIVE ACTION | 2022-08-10 | −$101,227 | $984,241 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00009· EXERCISE AN OPTION | 2022-10-13 | +$626,441 | $1,610,681 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00010· FUNDING ONLY ACTION | 2023-01-10 | +$0 | $1,610,681 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00011· EXERCISE AN OPTION | 2023-10-19 | +$621,820 | $2,232,501 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00012· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-06-05 | −$360 | $2,232,141 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00013· FUNDING ONLY ACTION | 2024-06-14 | −$7,734 | $2,224,407 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00014· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-10-28 | +$11,287 | $2,235,694 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00015· OTHER ADMINISTRATIVE ACTION | 2025-01-31 | +$0 | $2,235,694 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00016· FUNDING ONLY ACTION | 2025-11-03 | −$10 | $2,235,684 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
| Mod P00017· FUNDING ONLY ACTION | 2026-05-13 | −$85,128 | $2,150,556 | MOLECULAR HIV/PCR COST-PER-TEST&EQUIPMENT LEASE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JDMDFEZBYH36)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0794 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $200,000 | FY2026 |
| 36C25026N0788 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $135,282 | FY2026 |
| 36C25726N0474 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $21,384 | FY2026 |
| 36C25726C0089 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · J066 · MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT | $46,948 | FY2026 |
| 36C25926N0437 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $35,030 | FY2026 |
| 36C25926N0438 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $34,878 | FY2026 |
Other recipients under Q301 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726N0244 | SYSMEX AMERICA, INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $0 | FY2026 |
| 36C24726P0300 | QUEST DIAGNOSTICS INCORPORATED | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $6,574,968 | FY2026 |
| 36C24726P0412 | PATH-TEC LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $0 | FY2026 |
| 36C24726P0411 | MEDICAL UNIVERSITY HOSPITAL AUTHORITY | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $747,489 | FY2026 |
| 36C24726P0385 | ASSURED BIO LABS, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $14,987 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24720C0027_3600_-NONE-_-NONE- · retrieved 2026-09-26.